PUBLIC RELEASE DATE: 14-Apr-2014 Contact: Krista Conger kristac@stanford.edu 650-725-5371 Stanford University Medical Center STANFORD, Calif. As many as 10 percent of women with a personal or family history of breast or ovarian cancer have at least one genetic mutation that, if known, would prompt their doctors to recommend changes in their care, according to a new study by researchers at the Stanford University School of Medicine. The women in the study did not have mutations in BRCA1 or BRCA2 (mutations in these genes are strongly associated with hereditary breast and ovarian cancer), but they did have mutations in other cancer-associated genes. The study was conducted using what's known as a multiple-gene panel to quickly and cheaply sequence just a few possible genetic culprits selected by researchers based on what is known about a disease. Although such panels are becoming widely clinically available, it's not been clear whether their use can help patients or affect medical recommendations. "Although whole-genome sequencing can clearly be useful under the right conditions, it may be premature to consider doing on everyone," said James Ford, MD, who directs Stanford's Clinical Cancer Genetics Program. "Gene panels offer a middle ground between sequencing just a single gene like … Continue reading →

Sam Harrell's Stem Cell Journey: Stem Cell Therapy for Multiple Sclerosis Sam Harrell sent us this homemade video documenting his progress from 2010 until now (2014). Sam was coaching football at Ennis high school in Texas when MS ... By: http://www.cellmedicine.com … Continue reading →

Trinity final At the Trinity Stem Cell Institute our medical team is among the most renowned in the world for their research and development of stem cell therapy for back ... By: SMU Productions - Tampa Video Production … Continue reading →

By Estel Grace Masangkay Bone marrow stem cells may help in stroke recovery, according to a team of researchers from the University of California, Irvines Sue and Bill Gross Stem Cell Research Center. Neurologist Dr. Steven Cramer and biomedical engineer Weian Zhao together analyzed 46 studies evaluating the use of a type of multipotent adult stem cells mostly processed from the bone marrow called mesenchymal stromal cells (MSC) in animal models of stroke. Results showed that MSCs were superior to control therapy in 44 out of the 46 studies. Dr. Cramer said Stroke remains a major cause of disability, and we are encouraged that the preclinical evidence shows [MSCs] efficacy with ischemic stroke. MSCs are of particular interest because they come from bone marrow, which is readily available, and are relatively easy to culture. In addition, they already have demonstrated value when used to treat other human diseases. The MSCs effect on functional recovery was shown to be robust regardless of other factors such as dosage, time of administration relative to the stroke onset, or administration method. An earlier report focusing on MSC mechanisms of action explained how the cells were attracted to the injury sites and began releasing a … Continue reading →

Sam Harrell's Stem Cell Journey: Stem Cell Therapy for Multiple Sclerosis Sam Harrell sent us this homemade video documenting his progress from 2010 until now (2014). Sam was coaching football at Ennis high school in Texas when MS ... By: http://www.cellmedicine.com … Continue reading →